Loading…
The contextual role of TNFR family members in CD 8 + T‐cell control of viral infections
Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor ( TNF ) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific TNF receptor ( TNFR ) family members in antivira...
Saved in:
Published in: | Immunological reviews 2013-09, Vol.255 (1), p.125-148 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Immunity to viruses must be tightly controlled to avoid pathology. Receptors and ligands of the tumor necrosis factor (
TNF
) family play important roles in controlling lymphocyte activation and survival during an immune response. The role of specific
TNF
receptor (
TNFR
) family members in antiviral immunity depends on the stage of the immune response and can vary with the virus type and its virulence. Here, we focus on five members of the
TNFR
family that are prominently expressed on
CD
8
+
T cells during viral infections, namely, 4‐1
BB
(
CD
137),
CD
27,
OX
40 (
CD
134),
GITR
, and
TNFR
2. 4‐1
BB
,
CD
27,
OX
40, and
GITR
have primarily prosurvival roles for
CD
8
+
T cells during viral infection, although under some circumstances 4‐1
BB
,
GITR
, or
CD
27 signals can limit immunity. Although
TNFR
2 can be costimulatory under some circumstances, its main role in
CD
8
+
T‐cell responses during viral infection appears to be in contraction of the response. Several
TNF
family ligands are being explored as adjuvants for viral vaccines, and agonistic antibodies to
TNFR
family members are being investigated for immunotherapy of chronic viral infection alone and in combination with checkpoint blockade. Such therapies will require thorough and specific optimization to avoid pathology induced by hyperstimulation of these pathways. |
---|---|
ISSN: | 0105-2896 1600-065X |
DOI: | 10.1111/imr.12086 |